Use of the probability of stone formation (PSF) score to assess stone forming risk and treatment response in a cohort of Brazilian stone formers

Int Braz J Urol. 2014 Jul-Aug;40(4):507-12. doi: 10.1590/S1677-5538.IBJU.2014.04.09.

Abstract

Introduction: The aim was to confirm that PSF (probability of stone formation) changed appropriately following medical therapy on recurrent stone formers.

Materials and methods: Data were collected on 26 Brazilian stone-formers. A baseline 24-hour urine collection was performed prior to treatment. Details of the medical treatment initiated for stone-disease were recorded. A PSF calculation was performed on the 24 hour urine sample using the 7 urinary parameters required: voided volume, oxalate, calcium, urate, pH, citrate and magnesium. A repeat 24-hour urine sample was performed for PSF calculation after treatment. Comparison was made between the PSF scores before and during treatment.

Results: At baseline, 20 of the 26 patients (77%) had a high PSF score (> 0.5). Of the 26 patients, 17 (65%) showed an overall reduction in their PSF profiles with a medical treatment regimen. Eleven patients (42%) changed from a high risk (PSF > 0.5) to a low risk (PSF < 0.5) and 6 patients reduced their risk score but did not change risk category. Six (23%) patients remained in a high risk category (> 0.5) during both assessments.

Conclusions: The PSF score reduced following medical treatment in the majority of patients in this cohort.

MeSH terms

  • Adult
  • Aged
  • Calcium Phosphates / urine
  • Citrates / urine
  • Cohort Studies
  • Female
  • Humans
  • Magnesium / urine
  • Male
  • Middle Aged
  • Oxalates / urine
  • Probability
  • Reference Values
  • Reproducibility of Results
  • Risk Assessment / methods*
  • Risk Factors
  • Time Factors
  • Treatment Outcome
  • Uric Acid / urine
  • Urolithiasis / etiology
  • Urolithiasis / pathology
  • Urolithiasis / therapy*
  • Urolithiasis / urine*

Substances

  • Calcium Phosphates
  • Citrates
  • Oxalates
  • Uric Acid
  • calcium phosphate
  • Magnesium